Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
CANbridge Pharmaceuticals Inc. ( (HK:1228) ) has provided an update.
CANbridge Pharmaceuticals Inc. has announced the postponement of its board meeting originally scheduled for March 28, 2025, to March 31, 2025. The delay aims to ensure maximum attendance of directors for the approval of the company’s 2024 annual results, reflecting the company’s commitment to thorough governance and stakeholder transparency.
More about CANbridge Pharmaceuticals Inc.
CANbridge Pharmaceuticals Inc. is a biopharmaceutical company incorporated in the Cayman Islands, focusing on developing and commercializing innovative therapies for rare diseases and targeted cancers.
YTD Price Performance: 12.31%
Average Trading Volume: 1,123,339
Technical Sentiment Signal: Buy
Current Market Cap: HK$62.03M
For detailed information about 1228 stock, go to TipRanks’ Stock Analysis page.